Article Details
Retrieved on: 2022-01-25 16:57:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca PLC logo Barclays reaffirmed their overweight rating on shares of AstraZeneca (LON:AZN) in a research note issued to investors on ...
Article found on: etfdailynews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here